Global Continuous Renal Replacement Therapy Devices Market 2018-2022

持続的腎代替療法装置の世界市場2018-2022

◆タイトル:Global Continuous Renal Replacement Therapy Devices Market 2018-2022
◆商品コード:IRTNTR23363
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年12月21日
◆ページ数:129
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、持続的腎代替療法装置の世界市場について調査・分析し、市場概要、市場環境、持続的腎代替療法装置市場規模、モダリティ別(持続的静脈-静脈血液濾過(CVVH)、持続的静静脈血液ろ過透析(CVVHDF)、持続的静静脈血液透析(CVVHD)、持続的限外ろ過(SCUF))分析、製品別(消耗品、システム)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・持続的腎代替療法装置の世界市場概要
・持続的腎代替療法装置の世界市場環境
・持続的腎代替療法装置の世界市場動向
・持続的腎代替療法装置の世界市場規模
・持続的腎代替療法装置の世界市場:業界構造分析
・持続的腎代替療法装置の世界市場:モダリティ別(持続的静脈-静脈血液濾過(CVVH)、持続的静静脈血液ろ過透析(CVVHDF)、持続的静静脈血液透析(CVVHD)、持続的限外ろ過(SCUF))
・持続的腎代替療法装置の世界市場:製品別(消耗品、システム)
・持続的腎代替療法装置の世界市場:地域別市場規模・分析
・持続的腎代替療法装置の北米市場規模・予測
・持続的腎代替療法装置のヨーロッパ・中東・アフリカ市場規模・予測
・持続的腎代替療法装置のアジア太平洋市場規模・予測
・持続的腎代替療法装置の主要国分析
・持続的腎代替療法装置の世界市場:意思決定フレームワーク
・持続的腎代替療法装置の世界市場:成長要因、課題
・持続的腎代替療法装置の世界市場:競争環境
・持続的腎代替療法装置の世界市場:関連企業情報(ベンダー分析)

About this market
The incidence of AKIs in ICU patients is increasing, and severe cases of AKI are mostly treated through renal replacement therapy (RRT). CRRT is the most preferred therapy in ICU patients suffering from AKI due to their hemodynamic instability. Acute renal failures are common and can lead to serious complications in severely ill patients. The use of renal replacement therapy has a major impact in terms of treating acute renal failure. The timing of the initiation of the renal replacement therapy, the selection of the specific modality of the therapy, and the intensity of the therapy are the most important factors in determining the effectiveness of renal replacement therapy in treating acute renal failure. Technavio’s analysts have predicted that the continuous renal replacement therapy devices market will register a CAGR of over 7% by 2022.
Market Overview
Advantages of CRRT over IRRT
CRRT offers some key clinical advantages over intermittent blood purification techniques such as intermittent hemodialysis (IHD), sustained low-efficiency daily dialysis (SLEDD), and peritoneal dialysis (PD).

Limitations of and complications involved in CRRT
. Technical limitations such as the interaction between the technician or medical staff and the machine inhibit the quality of real-time data analytics carried out. These limitations apply both to the way in which patients are clinically managed and how the technology is used.
For the detailed list of factors that will drive and challenge the growth of the continuous renal replacement therapy devices market during the 2018-2022, view our report.
Competitive Landscape
The continuous renal replacement therapy devices market is moderately concentrated with companies. the increasing competition in mature markets, will further trigger CRRT device manufacturers to focus on the emerging markets during the forecast period. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY MODALITY
• Segmentation by modality
• Comparison by modality
• Global continuous venovenous hemofiltration (CVVH) market
• Global continuous venovenous hemodiafiltration (CVVHDF) market
• Global continuous venovenous hemodialysis (CVVHD) market
• Global slow continuous ultrafiltration (SCUF) market
• Market opportunity by modality
PART 08: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Global consumables market
• Global systems market
• Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• CRRT devices market in EMEA
• CRRT devices market in Americas
• CRRT devices market in APAC
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Opportunities in emerging markets
• Focus on miniaturization and wearable technology and that for infant and
• pediatric applications
• Technological advances in CRRT
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Asahi Kasei Medical (a subsidiary of Asahi Kasei Group)
• B. Braun Melsungen
• Baxter
• Fresenius Medical Care
• Medtronic
PART 16: APPENDIX
• List of abbreviations
PART 17: EXPLORE TECHNAVIO

Exhibit 01: Global urology devices market
Exhibit 02: Global urology devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Modality – Market share 2017-2022 (%)
Exhibit 19: Comparison by modality
Exhibit 20: Continuous venovenous hemofiltration (CVVH) – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Continuous venovenous hemofiltration (CVVH) – Year-over-year growth 2018-2022 (%)
Exhibit 22: Continuous venovenous hemodiafiltration (CVVHDF) – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Continuous venovenous hemodiafiltration (CVVHDF) – Year-over-year growth 2018-2022 (%)
Exhibit 24: Continuous venovenous hemodialysis (CVVHD) – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Continuous venovenous hemodialysis (CVVHD) – Year-over-year growth 2018-2022 (%)
Exhibit 26: Slow continuous ultrafiltration (SCUF) – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Slow continuous ultrafiltration (SCUF) – Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by modality
Exhibit 29: Product – Market share 2017-2022 (%)
Exhibit 30: Comparison by product
Exhibit 31: Consumables – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Consumables – Year-over-year growth 2018-2022 (%)
Exhibit 33: Systems – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Systems – Year-over-year growth 2018-2022 (%)
Exhibit 35: Market opportunity by product
Exhibit 36: Customer landscape
Exhibit 37: Global – Market share by geography 2017-2022 (%)
Exhibit 38: Regional comparison
Exhibit 39: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 40: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 41: Top three countries in EMEA
Exhibit 42: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 43: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 44: Top three countries in Americas
Exhibit 45: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 46: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 47: Top three countries in APAC
Exhibit 48: Market opportunity
Exhibit 49: Percentage of aging population 65 years and above (%)
Exhibit 50: Vendor landscape
Exhibit 51: Landscape disruption
Exhibit 52: Vendors covered
Exhibit 53: Vendor classification
Exhibit 54: Market positioning of vendors
Exhibit 55: Asahi Kasei Medical – Overview
Exhibit 56: Asahi Kasei Medical – Products category
Exhibit 57: Asahi Kasei Group – Geographic focus
Exhibit 58: Asahi Kasei Medical – Category focus
Exhibit 59: Asahi Kasei Medical – Key offerings
Exhibit 60: Asahi Kasei Medical – Key customers
Exhibit 61: B. Braun Melsungen – Overview
Exhibit 62: B. Braun Melsungen – Business segments
Exhibit 63: B. Braun Melsungen – Organizational developments
Exhibit 64: B. Braun Melsungen – Geographic focus
Exhibit 65: B. Braun Melsungen – Segment focus
Exhibit 66: B. Braun Melsungen – Key offerings
Exhibit 67: B. Braun Melsungen – Key customers
Exhibit 68: Baxter – Overview
Exhibit 69: Baxter – Business segments
Exhibit 70: Baxter – Organizational developments
Exhibit 71: Baxter – Geographic focus
Exhibit 72: Baxter – Segment focus
Exhibit 73: Baxter – Key offerings
Exhibit 74: Baxter – Key customers
Exhibit 75: Fresenius Medical Care – Overview
Exhibit 76: Fresenius Medical Care – Business segments
Exhibit 77: Fresenius Medical Care – Organizational developments
Exhibit 78: Fresenius Medical Care – Geographic focus
Exhibit 79: Fresenius Medical Care – Segment focus
Exhibit 80: Fresenius Medical Care – Key offerings
Exhibit 81: Fresenius Medical Care – Key customers
Exhibit 82: Medtronic – Overview
Exhibit 83: Medtronic – Business segments
Exhibit 84: Medtronic – Organizational developments
Exhibit 85: Medtronic – Geographic focus
Exhibit 86: Medtronic – Segment focus
Exhibit 87: Medtronic – Key offerings
Exhibit 88: Medtronic – Key customers



【掲載企業】

Asahi Kasei Medical (a subsidiary of Asahi Kasei Group)、B. Braun Melsungen、Baxter、Fresenius Medical Care、and Medtronic

★調査レポート[持続的腎代替療法装置の世界市場2018-2022] (Global Continuous Renal Replacement Therapy Devices Market 2018-2022 / IRTNTR23363)販売に関する免責事項
[持続的腎代替療法装置の世界市場2018-2022] (Global Continuous Renal Replacement Therapy Devices Market 2018-2022 / IRTNTR23363)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆